Palmer, B. F., Tumlin, J. A., Radhakrishnan, J., Rehaume, L. M., Cross, J. L., & Huizinga, R. B. (2025). The kidney injury biomarker profile of patients with lupus nephritis remains unchanged with the second-generation calcineurin inhibitor voclosporin. Frontiers in Nephrology, 5. https://doi.org/10.3389/fneph.2025.1540471

Llore, N., Schizza, A., Liou, P., Martinez, M., Lobritto, S., Emond, J., Kato, T., & Hawksworth, J. (2025). Building a Pediatric Robotic Hepatobiliary Surgery Program at Columbia University Hospital. American Journal of Transplantation, 25(1), S57. https://doi.org/10.1016/j.ajt.2024.12.116

Llore, N., & Hawksworth, J. (2024). Cutting Down Biliary Complications in Living Donor Hepatectomy: Enter the Robot. Transplantation. https://doi.org/10.1097/tp.0000000000005277

Reis, S. P., Haider, S., Brejt, S., Ahmad, N., & Sperling, D. (2024). Transjugular Intrahepatic Portosystemic Shunt (TIPS) Check and Revision in a Freestanding Outpatient Facility: Safety and Efficacy. Cureus. https://doi.org/10.7759/cureus.74517

Al-Karaghouli, M., Ventura-Cots, M., Wong, Y. J., Genesca, J., Bosques, F., Brown, R. S., Mathurin, P., Louvet, A., Shawcross, D., Vargas, V., Verna, E. C., Schnabl, B., Caballeria, J., Shah, V. J., Kamath, P. S., Lucey, M. R., Garcia-Tsao, G., Bataller, R., & Abraldes, J. G. (2024). Relationship between updated MELD and prognosis in alcohol-associated hepatitis: Opportunities for more efficient trial design. Hepatology Communications, 8(8). https://doi.org/10.1097/hc9.0000000000000495

Liou, P. H., & Emond, J. C. (2024). Machine Preservation and the Full Potential of Split Liver Transplantation. Transplantation, 108(6), 1275–1276. https://doi.org/10.1097/tp.0000000000005067

Petta, S., Targher, G., Romeo, S., Pajvani, U. B., Zheng, M., Aghemo, A., & Valenti, L. V. C. (2024). The first MASH drug therapy on the horizon: Current perspectives of resmetirom. Liver International, 44(7), 1526–1536. Portico. https://doi.org/10.1111/liv.15930

Stern, L., Johnson, R. J., Shakouri, P., Athavale, A., Padnick-Silver, L., LaMoreaux, B., Marder, B. A., & Mandayam, S. (2024). Prevalence and Influence of Gout in Patients with Advanced Chronic Kidney Disease: Findings of a Large Retrospective Chart Review. Gout, Urate, and Crystal Deposition Disease, 2(1), 77–85. https://doi.org/10.3390/gucdd2010008

Phipps, M. M., Choi, A. J., & Brown Jr, R. S. (2024). Narrative review of management of cirrhosis during the treatment of hepatocellular carcinoma. Annals of Palliative Medicine, 13(1), 141–149. https://doi.org/10.21037/apm-23-173

Wang, X., Moore, M. P., Shi, H., Miyata, Y., Donnelly, S. K., Radiloff, D. R., & Tabas, I. (2023). Hepatocyte-targeted siTAZ therapy lowers liver fibrosis in NASH diet-fed chimeric mice with hepatocyte-humanized livers. Molecular Therapy - Methods & Clinical Development, 31, 101165. https://doi.org/10.1016/j.omtm.2023.101165

Martinez, M., Kang, E., Beltramo, F., Nares, M., Jeyapalan, A., Alcamo, A., Monde, A., Ridall, L., Kamath, S., Betters, K., Rowan, C., Mangus, R. S., Kaushik, S., Zinter, M., Resch, J., & Maue, D. (2023). Vascular thrombosis after pediatric liver transplantation: Is prevention achievable? Journal of Liver Transplantation, 12, 100185. https://doi.org/10.1016/j.liver.2023.100185

Zavala, S., DeLaurentis, C., Aaron, J. G., Miko, B. A., Fox, A. N., Bergelson, M., DeVore, A., Segovia, M. C., Wolfe, C. R., & Pereira, M. R. (2023). When you need to dive in the deep end—Transplanting SARS‐CoV‐2 PCR+ recipients. Transplant Infectious Disease, 25(5). Portico. https://doi.org/10.1111/tid.14110

Hagström, H., Thiele, M., Sharma, R., Simon, T. G., Roelstraete, B., Söderling, J., Sundström, J., & Ludvigsson, J. F. (2023). Cardiovascular Outcomes in Patients With Biopsy-proven Alcohol-related Liver Disease. Clinical Gastroenterology and Hepatology, 21(7), 1841-1853.e12. https://doi.org/10.1016/j.cgh.2022.10.022

See, S. B., Yang, X., Burger, C., Lamarthée, B., Snanoudj, R., Shihab, R., Tsapepas, D. S., Roy, P., Larivière-Beaudoin, S., Hamelin, K., Mendoza Rojas, A., van Besouw, N. M., Bartosic, A., Daniel, N., Rodica, V. E., Mohan, S., Cohen, D., Ratner, L., Baan, C. C., … Zorn, E. (2023). Natural Antibodies Are Associated With Rejection and Long-term Renal Allograft Loss in a Multicenter International Cohort. Transplantation, 107(7), 1580–1592. https://doi.org/10.1097/tp.0000000000004472

Sharma, R., Schluger, A., Ahmed, F. S., Nobel, Y. R., Guo, X., Zhao, B., & Verna, E. C. (2023). Visceral adiposity in cirrhosis: Association with disease severity and impact of liver transplantation. Hepatology Communications, 7(6). https://doi.org/10.1097/hc9.0000000000000113

Barman, P. M., Patel, Y. A., Xie, J., Zhang, M., Jo, J., Sinha, J., Answine, A., Schluger, A., Walter, K., Biggins, S. W., Cullaro, G., Wong, R., Lai, J. C., VanWagner, L. B., Magee, J., Verna, E. C., & Sharma, P. (2022). Predictors of Length of Stay and Mortality During Simultaneous Liver-Kidney Transplant Index Admission: Results From the US-Multicenter SLKT Consortium. Transplantation Direct, 8(12), e1408. https://doi.org/10.1097/txd.0000000000001408

Tabrizian, P., Holzner, M. L., Mehta, N., Halazun, K., Agopian, V. G., Yao, F., Busuttil, R. W., Roberts, J., Emond, J. C., Samstein, B., Brown, R. S., Najjar, M., Chapman, W. C., Doyle, M. Mb., Florman, S. S., Schwartz, M. E., & Llovet, J. M. (2022). Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma. JAMA Surgery. https://doi.org/10.1001/jamasurg.2022.2800

Guber, K., Zilinyi, R. S., Driggin, E., Soroush, A., Welinsky, S., Nathanson, J., Sethi, A., & Rubin, D. (2022). Rare Complication of Endoscopic Variceal Therapy. JACC: Case Reports, 4(7), 433–437. https://doi.org/10.1016/j.jaccas.2021.11.008

Hagström, H., Thiele, M., Simon, T. G., Sharma, R., Röckert Tjernberg, A., Roelstraete, B., Söderling, J., & Ludvigsson, J. F. (2022). Risk of infections and their role on subsequent mortality in biopsy‐proven alcohol‐related liver disease. United European Gastroenterology Journal, 10(2), 198–211. Portico. https://doi.org/10.1002/ueg2.12200